ABOUT BRUKER CELLULAR ANALYSIS
Bruker Cellular Analysis is revolutionizing life science research by empowering scientists to explore single-cell biology with unmatched precision. Through live single-cell multiomics, Bruker enables researchers to understand the life of single cells, driving breakthroughs that will shape the future of functional cell biology and improve human health. Their suite of advanced, high-throughput tools offers unprecedented resolution and speed, helping scientists gain deeper insights into cellular behavior and molecular mechanism to transform disease prevention and treatment.
At the core of innovation is the Beacon® Optofluidic System, which provides a comprehensive view of single-cell function through real-time imaging and multi-modal analysis of tens of thousands of cells simultaneously. Leveraging cutting-edge Light-driven Opto-Electro Positioning (OEP) and NanoPen® technologies, Beacon allows researchers to perform customized, non-invasive experiments on live cells, linking on-chip functional data with off-chip sequencing data. With tailored workflows for applications like immune cell profiling, CAR/TCR discovery, antibody discovery and cell line development, Bruker Cellular Analysis is driving the next era of biomedical discovery.
FEATURED CONTENT
-
![GettyImages-879828000-lab-cell-microscope]( "Leveraging Real-Time Biology To Streamline Cell-Based Therapies For Cancer")
Discover how real-time biology accelerates cancer cell therapy development. This talk highlights three case studies focused on TCR T cells, CAR T cell properties, and immunotherapy comparisons.
-
![GettyImages-483098985-lab-cell-plasmid-sample-pipette]( "Revolutionizing Adoptive Cell Therapy Development With Optofluidic Platform")
Learn how an innovative optofluidic platform empowers researchers to gain a deeper understanding of single-cell functionality, accelerating the development of effective adoptive cell therapies.
-
![GettyImages-1146505098 T Cell]( "Accelerating CAR And TCR Discovery With Single-Cell Functional Screening")
Learn about the effectiveness of single-cell functional screening for CAR and TCR candidates, offering a powerful solution for functional-based target discovery.
-
![GettyImages-164198023 lab, research]( "Validating Performance Of Immune Cells At A Single-Cell Level")
Optofluidic platforms can provide detailed insights into immune cell heterogeneity for validating adoptive cell therapies, streamlining development processes, and advancing clinical applications.
-
![GettyImages-1327073953 scientist, lab, experiment, biomarker]( "Unveiling Critical Translational Biomarkers Through Single-Cell Analysis")
single-cell analysis can be used to identify critical biomarkers, revealing functional heterogeneity among donor products and correlating them with clinical outcomes in adoptive cell therapy.
-
![GettyImages-1302640919 monoclonal antibodies]( "Enabling Multispecies Screening Capabilities")
Learn how researchers can efficiently identify monoclonal antibodies from a broader B cell repertoire, accelerating the discovery process for therapeutic applications.
-
![Bruker - beacon]( "Expedite Cell Line Development Timelines With Selective Cell Cloning")
Selective cell cloning accelerates cell line development timelines by enabling data-driven clone selection based on key markers, leading to faster and more efficient biotherapeutic development.
-
![GettyImages-1133973085-monoclonal-antibody]( "Cutting Difficult Targets Down To Size")
Discover a plasma B discovery workflow that addresses these problems by using cutting edge single-cell screening technology to revolutionize antibody discovery.
-
![GettyImages-963804760-t-cell-cancer-cell]( "Characterize T Cell Exhaustion And Hypofunctionality In Cancer")
Investigate what drives the hypofunctional state of T cells in ICB-nonresponsive cancers through the characterization of CD8+ T cell functionality in different tumor types.
CONTACT INFORMATION
Bruker Cellular Analysis
858 Horton St., Suite 320
Emeryville, CA 94608
UNITED STATES
Contact: Jillian Romeo
